Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Photo Evaluation
Study Details
Study Description
Brief Summary
The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINBACK Tangerine Mix (Lactic Acid).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Lactic Acid |
Drug: Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)
Lactic Acid
|
Outcome Measures
Primary Outcome Measures
- The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. [Throughout the study]
- The sensibility will be evaluated according to the skin type. [Throghout the study]
Eligibility Criteria
Criteria
Inclusion criteria:
-
Age between 18 and 60 years old;
-
Phototype Skin II and III;
-
Integral skin test in the region;
-
Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;
Exclusion criteria:
-
Lactation or gestation
-
Use of Antiinflammatory and/or immunossupression drugs 15 days before the selection;
-
Diseases which can cause immunity decrease, such as HIV, diabetes;
-
Use of drug photosensitizer;
-
History of sensitivity or irritation for topic products;
-
Active cutaneous disease which can change the study results;
-
History of photodermatosis active;
-
Family or personal antecedent of cutaneous photoinduced neoplasias;
-
Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and queratoses actinium;
-
Intense solar exposure in the study area;
-
Use of new drugs or cosmetics during the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sanofi-Aventis Administrative Office | Sao Paulo | Brazil |
Sponsors and Collaborators
- Sanofi
Investigators
- Study Director: Jaderson Lima, Sanofi
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LACAC_L_04309